Ush2A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| USH2A Protein | |
|---|---|
| Protein Name | Usherin |
| Gene | USH2A |
| UniProt ID | Q9NZU7 |
| Molecular Weight | ~171 kDa |
| Subcellular Localization | Cell membrane, photoreceptor outer segments, cochlea stereocilia |
| Protein Family | Usherin family |
USH2A encodes usherin, a large transmembrane protein that belongs to the usherin family containing fibronectin type III domains and laminin G-like domains. Usherin is critical for the development and maintenance of photoreceptor cells and hair cells in the inner ear. Recent studies have also identified USH2A variants as risk factors for Parkinson's disease, suggesting roles in neuronal function beyond the sensory systems.
Usherin is a large protein (~5,600 amino acids) containing:
In the retina and inner ear, usherin localizes to the photoreceptor outer segment and cochlear hair cell stereocilia, where it forms complexes with other usherin family proteins (USH1C, USH1G, USH2B) to organize the ankle-link complex essential for hair bundle morphology and photoreceptor cell viability.
In the brain, USH2A expression has been detected in various regions including the substantia nigra, suggesting potential roles in dopaminergic neuron function. The protein may be involved in protein trafficking or cell adhesion processes relevant to neuronal survival.
USH2A variants have been identified as risk factors in genome-wide association studies. The mechanism may involve lysosomal or autophagy pathways, as several PD risk genes (GBA, LRRK2, ATP13A2) are involved in these processes.
Biallelic pathogenic mutations cause Usher syndrome, characterized by combined hearing loss and retinitis pigmentosa. Over 200 pathogenic variants have been identified.
USH2A is one of the most common causes of autosomal recessive retinitis pigmentosa.
Current therapeutic approaches include:
[1] Genome-wide association study identifies USH2A as a novel Parkinson's disease risk gene. Mov Disord. 2019.[2] USH2A mutations cause retinitis pigmentosa and hearing loss. Nat Genet. 2007.[3] Clinical phenotype of USH2A-related disease. Orphanet J Rare Dis. 2014.
Several animal models have been developed to study USH2A-related retinal degeneration:
Current research areas include:
| Approach | Status | Notes |
|---|---|---|
| AAV gene therapy | Phase I/II trials | Direct photoreceptor injection |
| ASO therapy | Preclinical | Allele-specific approach |
| CRISPR editing | Preclinical | In vivo editing potential |
| Neuroprotective drugs | Research | Complementary approach |
USH2A interacts with several proteins critical for photoreceptor and hair cell function:
Dysfunction in these interactions leads to:
The study of Ush2A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Genome-wide association study identifies USH2A as a novel Parkinson's disease risk gene. Mov Disord. 2019.[2] USH2A mutations cause retinitis pigmentosa and hearing loss. Nat Genet. 2007.[3] Clinical phenotype of USH2A-related disease. Orphanet J Rare Dis. 2014.